Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

ClinicalTrials.gov ID: NCT00806546

Public ClinicalTrials.gov record NCT00806546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will use an open-label design to evaluate the safety of NP101. Adult subjects who meet the enrollment criteria will be treated with NP101 (sumatriptan succinate iontophoretic transdermal patch) for acute migraine attacks over a 12 month period.

Study identification

NCT ID
NCT00806546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NuPathe Inc.
Industry
Enrollment
514 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2009 (Type not available)
Primary completion
May 2011 (Actual)
Completion
May 2011 (Actual)
Last update posted
Feb 4, 2016

2009 – 2011

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Not listed Phoenix Arizona — —
Not listed Scottsdale Arizona — —
Not listed Irvine California — —
Not listed Newport Beach California — —
Not listed San Francisco California — —
Not listed Santa Monica California — —
Not listed Walnut Creek California — —
Not listed Fairfield Connecticut — —
Not listed Hallandale Florida — —
Not listed Ocala Florida — —
Not listed Sunrise Florida — —
Not listed Atlanta Georgia — —
Not listed Decatur Georgia — —
Not listed Savannah Georgia — —
Not listed Crestview Hills Kentucky — —
Not listed Ann Arbor Michigan — —
Not listed St Louis Missouri — —
Not listed Mount Vernon New York — —
Not listed Plainview New York — —
Not listed Greensboro North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Cleveland Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Philadelphia Pennsylvania — —
Not listed Pittsburgh Pennsylvania — —
Not listed Clarksville Tennessee — —
Not listed Dallas Texas — —
Not listed San Antonio Texas — —
Not listed Alexandria Virginia — —
Not listed Virginia Beach Virginia — —
Not listed Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00806546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00806546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →